Page last updated: 2024-08-24

loxiglumide and Invasiveness, Neoplasm

loxiglumide has been researched along with Invasiveness, Neoplasm in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hanada, K; Hirata, M; Itoh, M; Kajiyama, G; Ooishi, H; Tsuchida, A	1

Other Studies

1 other study(ies) available for loxiglumide and Invasiveness, Neoplasm

Article	Year
Cholecystokinin receptor antagonist, loxiglumide, inhibits invasiveness of human pancreatic cancer cell lines. FEBS letters, 1996, Apr-01, Volume: 383, Issue:3 Topics: Blotting, Western; Cell Line; Collagenases; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Gelatin; Hormone Antagonists; Humans; Kinetics; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Pancreatic Neoplasms; Proglumide; Sincalide; Tumor Cells, Cultured	1996

Article

Year

Cholecystokinin receptor antagonist, loxiglumide, inhibits invasiveness of human pancreatic cancer cell lines.

FEBS letters, 1996, Apr-01, Volume: 383, Issue:3

Topics: Blotting, Western; Cell Line; Collagenases; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Gelatin; Hormone Antagonists; Humans; Kinetics; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Pancreatic Neoplasms; Proglumide; Sincalide; Tumor Cells, Cultured

1996